When looking for a place to grow a life sciences business over the long term, sometimes the biggest location isn't ...

Clean, humanized data and data systems are the crucial fuel for engines driving new AI capabilities and uses across the ...

The FDA's new FAQ on cell and gene therapy offers a roadmap for developers. Review key insights from the document, including ...

Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski explain the importance of transparency and collaboration when encountering manufacturing speed bumps.

Woody Bryan, Ph.D. has founded several biotech companies during his career, and he explains how his journey from scientist to business development prepared him for the C-suite.

Few drug discovery and development concepts are as hyped, and as such, draw as much polarity from drug developers, as machine learning and artificial intelligence. One company on the bullish end of ...

Biopharma guru Allan Shaw speculates on the risks and benefits that the incoming Trump administration could bring to the industry.

Since 2008, PCM Trials has led the way in mobile research. Our Certified Mobile Research Nurses (CMRNs) are driving the shift to patient-centric, decentralized clinical trials, giving individuals the ...

Dr. Tal Zaks is back, along with Advancing RNA's Anna Rose Welch, for part 2 of "Story Time With Tal." On this week's episode, we turn from his time navigating medical affairs as CMO at Moderna during ...